Septerna (SEPN) Other Gross PP&E Adjustments (2023 - 2026)
Septerna's quarterly Other Gross PP&E Adjustments came in at -$11.8 million in Q1 2026, up 19.6% year-on-year from -$9.9 million in Q1 2025, and up 10.28% quarter-over-quarter from -$13.2 million in Q4 2025.
Septerna has reported Other Gross PP&E Adjustments for 4 years, with the latest figure at -$11.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 19.6% year-over-year to -$11.8 million; the trailing twelve-month figure through Mar 2026 stood at -$11.8 million (up 19.6% YoY), and the FY2025 full-year result was -$13.2 million, up 15.71% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$11.8 million, up from -$13.2 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$6.2 million in Q4 2023, with the low at -$16.1 million in Q3 2024.
- Average Other Gross PP&E Adjustments over 4 years is -$13.2 million, with a median of -$13.9 million recorded in 2025.
- Year-over-year, Other Gross PP&E Adjustments sank 150.54% in 2024 and increased 19.6% in 2026.
- Tracing SEPN's Other Gross PP&E Adjustments over 4 years: stood at -$6.2 million in 2023, then tumbled by 150.54% to -$15.6 million in 2024, then rose by 15.71% to -$13.2 million in 2025, then rose by 10.28% to -$11.8 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$11.8 million (Q1 2026), -$13.2 million (Q4 2025), and -$13.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | -11.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.83 Mn |
| Mar 31, 2026 | -11.83 Mn |
| Dec 31, 2025 | -13.19 Mn |
| Dec 31, 2025 | -13.19 Mn |
| Sep 30, 2025 | -13.66 Mn |
| Sep 30, 2025 | -13.66 Mn |
| Jun 30, 2025 | -14.16 Mn |
| Jun 30, 2025 | -14.16 Mn |
| Mar 31, 2025 | -14.72 Mn |
| Mar 31, 2025 | -14.72 Mn |
| Dec 31, 2024 | -15.64 Mn |
| Dec 31, 2024 | -15.64 Mn |
| Sep 30, 2024 | -16.14 Mn |
| Sep 30, 2024 | -16.14 Mn |
| Dec 31, 2023 | -6.24 Mn |
| Dec 31, 2023 | -6.24 Mn |